{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:57Z","timestamp":1740108477349,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s00296-015-3297-y","type":"journal-article","created":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T06:45:10Z","timestamp":1433141110000},"page":"1781-1789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Polymyalgia rheumatica: strategies for efficient practice and quality assurance"],"prefix":"10.1007","volume":"35","author":[{"given":"Michael","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9208-7809","authenticated-orcid":false,"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"issue":"1","key":"3297_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, National Deyo RA, Workgroup Arthritis Data et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58(1):26\u201335","journal-title":"Arthritis Rheum"},{"key":"3297_CR2","first-page":"1694","volume":"29","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, O\u2019Fallon WM, Hunder GG, Gabriel SE (2002) Trends in the incidence of polymyalgia rheumatica over a 30\u00a0year period in Olmsted County, Minnesota, USA. J Rheumatol 29:1694\u20131697","journal-title":"J Rheumatol"},{"issue":"6","key":"3297_CR3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archinte.159.6.577","volume":"159","author":"CM Weyand","year":"1999","unstructured":"Weyand CM, Fulbright JW, Evans JM, Hunder GG, Goronzy JJ (1999) Corticosteroid requirements in polymyalgia rheumatica. Arch Int Med 159(6):577\u2013584","journal-title":"Arch Int Med"},{"issue":"4","key":"3297_CR4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3899\/jrheum.110977","volume":"39","author":"EL Matteson","year":"2012","unstructured":"Matteson EL, Maradit-Kremers H, Cimmino MA, Schmidt WA, Schirmer M, Salvarani C et al (2012) Patient reported outcomes in polymyalgia rheumatica. J Rheumatol 39(4):795\u2013803","journal-title":"J Rheumatol"},{"issue":"5","key":"3297_CR5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.22777","volume":"57","author":"A Hutchings","year":"2007","unstructured":"Hutchings A, Hollywood J, Lamping DL, Pease CT, Chakravarty K, Silverman B et al (2007) Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum 57(5):803\u2013809","journal-title":"Arthritis Rheum"},{"key":"3297_CR6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H, Schmidt WA, Schirmer M, Salvarani C et al (2012) European League Against Rheumatism\/American College of Rheumatology provisional classification criteria for polymyalgia rheumatica. Ann Rheum Dis 71:484\u2013492","journal-title":"Ann Rheum Dis"},{"key":"3297_CR7","first-page":"3996","volume-title":"Handbook of disease burdens and quality of life measures","author":"H Maradit-Kremers","year":"2009","unstructured":"Maradit-Kremers H, Dasgupta B, Matteson EL (2009) Polymyalgia rheumatica. In: Preedy VR, Watson RR (eds) Handbook of disease burdens and quality of life measures. Springer, Berlin, pp 3996\u20134012"},{"issue":"1","key":"3297_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"BSR and BHPR Standards, Guidelines and Audit Working Group, Dasgupta B, Borg FA, Hassan N, Barraclough K, Bourke B, Fulcher J et al (2010) BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 49(1):186\u2013190","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 47","key":"3297_CR9","first-page":"S130","volume":"25","author":"B Dasgupta","year":"2007","unstructured":"Dasgupta B, Matteson EL, Maradit-Kremers H (2007) Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol 25(suppl 47):S130\u2013S136","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl2","key":"3297_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/annrheumdis-2014-eular.2271","volume":"73","author":"C Dejaco","year":"2014","unstructured":"ACR\/EULAR PMR Guidelines Development Group, Dejaco C, Singh Y, Perel P, Hutchings A, Matteson EL, Dasgupta B (2014) Current evidence for therapeutic interventions in polymyalgia rheumatica (PMR): a systematic literature review informing the ACR\/EULAR recommendations for the management of PMR. Ann Rheum Dis 73(suppl2):552","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3297_CR11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261\u2013271","journal-title":"N Engl J Med"},{"issue":"1","key":"3297_CR12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1056\/NEJMcp1214825","volume":"371","author":"CM Weyand","year":"2014","unstructured":"Weyand CM, Goronzy JJ (2014) Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371(1):50\u201357","journal-title":"N Engl J Med"},{"key":"3297_CR13","first-page":"2179","volume":"27","author":"MA Gonzalez-Gay","year":"2000","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG (2000) The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 27:2179\u20132184","journal-title":"J Rheumatol"},{"issue":"12","key":"3297_CR14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/rheumatology\/kep286","volume":"48","author":"P Macchioni","year":"2009","unstructured":"Macchioni P, Catanoso MG, Pipitone N, Boiardi L, Salvarani C (2009) Longitudinal examination with shoulder ultrasound of patients with polymyalgia rheumatica. Rheumatology (Oxford) 48(12):1566\u20131569","journal-title":"Rheumatology (Oxford)"},{"issue":"1 Suppl 70","key":"3297_CR15","first-page":"S34","volume":"30","author":"E Miguel De","year":"2012","unstructured":"De Miguel E, Roxo A, Castillo C, Peiteado D, Villalba A, Martin-Mola E (2012) The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol 30(1 Suppl 70):S34\u2013S38","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3297_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00393-012-1103-8","volume":"72","author":"WA Schmidt","year":"2013","unstructured":"Schmidt WA (2013) Polymyalgia rheumatica. Z Rheumatol 72(1):59\u201365","journal-title":"Z Rheumatol"},{"issue":"2","key":"3297_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","volume":"37","author":"B Dasgupta","year":"1998","unstructured":"Dasgupta B, Dolan AL, Panayi GS, Fernandes L (1998) An initially double-blind controlled 96\u00a0week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica. Br J Rheumatol 37(2):189\u2013195","journal-title":"Br J Rheumatol"},{"issue":"12","key":"3297_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/ard.52.12.847","volume":"52","author":"V Kyle","year":"1993","unstructured":"Kyle V, Hazleman BL (1993) The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first 2\u00a0months of treatment. Ann Rheum Dis 52(12):847\u2013850","journal-title":"Ann Rheum Dis"},{"issue":"20","key":"3297_CR19","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","volume":"169","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2009","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Cid MC, L\u00f3pez-Soto A, Espigol-Frigol\u00e9 G, Bosch X (2009) Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med 169(20):1839\u20131850","journal-title":"Arch Intern Med"},{"issue":"1","key":"3297_CR20","first-page":"65","volume":"32","author":"HM Maradit Kremers","year":"2005","unstructured":"Maradit Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 32(1):65\u201373","journal-title":"J Rheumatol"},{"key":"3297_CR21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","volume":"49","author":"SL Mackie","year":"2010","unstructured":"Mackie SL, Hensor EM, Haugeberg G, Bhakta B, Pease CT (2010) Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford) 49:716\u2013722","journal-title":"Rheumatology (Oxford)"},{"key":"3297_CR22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","volume":"30","author":"G Myklebust","year":"2001","unstructured":"Myklebust G, Gran JT (2001) Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective 2-year study in 273 patients. Scand J Rheumatol 30:260\u2013267","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"3297_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/art.21160","volume":"53","author":"H Maradit Kremers","year":"2005","unstructured":"Maradit Kremers H, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease. Arthr Care Res 53(3):395\u2013403","journal-title":"Arthr Care Res"},{"issue":"4","key":"3297_CR24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.21311","volume":"53","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Direct medical costs of polymyalgia rheumatica. Arthritis Rheum 53(4):578\u2013584","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3297_CR25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C et al (2004) Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 141(7):493\u2013500","journal-title":"Ann Intern Med"},{"issue":"4","key":"3297_CR26","first-page":"624","volume":"23","author":"G Ferraccioli","year":"1996","unstructured":"Ferraccioli G, Salaffi F, De Vita S, Casatta L, Bartoli E (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 23(4):624\u2013628","journal-title":"J Rheumatol"},{"issue":"4","key":"3297_CR27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","volume":"55","author":"MJ Veen van der","year":"1996","unstructured":"van der Veen MJ, Dinant HJ, van Booma-Frankfort C, van Albada-Kuipers GA, Bijlsma JW (1996) Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? Ann Rheum Dis 55(4):218\u2013223","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3297_CR28","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","volume":"40","author":"SE Gabriel","year":"1997","unstructured":"Gabriel SE, Sunku J, Salvarani C, O\u2019Fallon WM, Hunder GG (1997) Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 40(10):1873\u20131878","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3297_CR29","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3899\/jrheum.110866","volume":"39","author":"C Cleuziou","year":"2012","unstructured":"Cleuziou C, Binard A, De Bandt M, Berthelot JM, Saraux A (2012) Contribution of the polymyalgia rheumatica activity score to glucocorticoid dosage adjustment in everyday practice. J Rheumatol 39(2):310\u2013313","journal-title":"J Rheumatol"},{"issue":"6","key":"3297_CR30","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/annrheumdis-2013-204167","volume":"73","author":"P Macchioni","year":"2014","unstructured":"Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C (2014) Performance of the new 2012 EULAR\/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis 73(6):1190\u20131193","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3297_CR31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3899\/jrheum.131254","volume":"41","author":"SL Mackie","year":"2014","unstructured":"Mackie SL, Arat S, da Silva J, Duarte C, Halliday S, Hughes R et al (2014) Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR. J Rheumatol 41(4):819\u2013823","journal-title":"J Rheumatol"},{"issue":"5","key":"3297_CR32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.22771","volume":"57","author":"BF Leeb","year":"2007","unstructured":"Leeb BF, Rintelen B, Sautner J, Fassl C, Bird HA (2007) The polymyalgia rheumatica activity score in daily use: proposal for a definition of remission. Arthritis Rheum 57(5):810\u2013815","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3297_CR33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.23338","volume":"59","author":"A Binard","year":"2008","unstructured":"Inflammatory Joint Disease Working Group of the French Society for Rheumatology, Binard A, de Bandt M, Berthelot JM, Saraux A (2008) Performance of the polymyalgia rheumatica activity score for diagnosing disease flares. Arthritis Rheum 59(2):263\u2013269","journal-title":"Arthritis Rheum"},{"key":"3297_CR34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s100670070045","volume":"19","author":"S Bahlas","year":"2000","unstructured":"Bahlas S, Ramos-Remus C, Davis P (2000) Utilisation and costs of investigations, and accuracy of diagnosis of polymyalgia rheumatica by family physicians. Clin Exp Rheumatol 19:278\u2013280","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3297_CR35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","volume":"70","author":"C Dejaco","year":"2011","unstructured":"Dejaco C, Duftner C, Cimmino MA, Dasgupta B, Salvarani C, Crowson CS et al (2011) Definition of remission and relapse in polymyalgia rheumatica\u2014data from a literature search compared to a Delphi based expert consensus. Ann Rheum Dis 70(3):447\u2013453","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3297_CR36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/39.8.883","volume":"39","author":"S Kalke","year":"2000","unstructured":"Kalke S, Mukerjee D, Dasgupta B (2000) A study of the health assessment questionnaire to evaluate functional status in polymyalgia rheumatica. Rheumatology (Oxford) 39(8):883\u2013885","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3297_CR37","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","volume":"40","author":"JT Gran","year":"2001","unstructured":"Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK (2001) Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 40(11):1238\u20131242","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3297-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-015-3297-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-015-3297-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:31Z","timestamp":1559028511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-015-3297-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3297"],"URL":"https:\/\/doi.org\/10.1007\/s00296-015-3297-y","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}